Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis
Primary Purpose
Fatigue
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
KRG (Korea Red ginseng)
Placebo (for KRG)
Sponsored by
About this trial
This is an interventional treatment trial for Fatigue focused on measuring Fatigue, Panax ginseng, Chronic hepatitis, Non-alcoholic Fatty Liver Disease, Adiponectin
Eligibility Criteria
Inclusion Criteria:
- aspartate aminotransferase (AST) ≥ 50 U/L or alanine aminotransferase (ALT) ≥ 50 U/L, and Fatty liver or Hepatitis
Exclusion Criteria:
- viral hepatitis, alcoholic hepatitis, autoimmune hepatitis, pancreatitis, hemochromatosis, Wilson's disease, drug induced liver injury, or cancer
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Korea Red Ginseng (KRG)
Placebo (for KRG)
Arm Description
KRG capsule (3,000 mg/day) for 3 weeks
placebo (for KRG) for 3 weeks
Outcomes
Primary Outcome Measures
Liver Enzymes
aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase
Secondary Outcome Measures
Fatigue as Measured by KRUPP's Fatigue Severity Scale
KRUPP's fatigue severity scale.
The survey has nine questions as following:
my motivation is lower, when I am fatigued
exercise brings on my fatigue
I am easily fatigued
fatigue interferes with my physical functioning
fatigue causes frequent problems for me
my fatigue prevents sustained physical functioning
fatigue interferes with carrying out certain duties and responsibilities
fatigue is among my 3 most disabling symptoms
fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree).
Scores range from 9 to 63, with higher scores indicating higher fatigue
Pro-inflammatory Cytokine
tumor necrosis factor-alpha, interleukin-6
Adiponectin
enzyme-linked immunosorbent assay
Full Information
NCT ID
NCT02331589
First Posted
December 31, 2014
Last Updated
February 8, 2015
Sponsor
Chuncheon Sacred Heart Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02331589
Brief Title
Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis
Official Title
Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
April 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chuncheon Sacred Heart Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Background: Korea red ginseng (KRG) has anti-carcinogenic activity, anti-oxidant activity, and cancer related anti-fatigue.
Methods: Seventy five patients with non-alcoholic hepatitis were prospectively randomized to receive 3 weeks of KRG or placebo. Liver function test, pro-inflammatory cytokines, adiponectin, fatigue severity scale, and antioxidant activity were check and compared.
Detailed Description
Fatigue Severity Scale
We used to be KRUPP's fatigue severity scale. The survey has nine questions as following: (1) my motivation is lower, when I am fatigued (2) exercise brings on my fatigue (3) I am easily fatigued (4) fatigue interferes with my physical functioning (5) fatigue causes frequent problems for me (6) my fatigue prevents sustained physical functioning (7) fatigue interferes with carrying out certain duties and responsibilities (8) fatigue is among my 3 most disabling symptoms (9) fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree). All fatigue severity scale calculated and collected by one research nurse (C.W.K) in the Department of Internal Medicine.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fatigue
Keywords
Fatigue, Panax ginseng, Chronic hepatitis, Non-alcoholic Fatty Liver Disease, Adiponectin
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
75 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Korea Red Ginseng (KRG)
Arm Type
Active Comparator
Arm Description
KRG capsule (3,000 mg/day) for 3 weeks
Arm Title
Placebo (for KRG)
Arm Type
Placebo Comparator
Arm Description
placebo (for KRG) for 3 weeks
Intervention Type
Drug
Intervention Name(s)
KRG (Korea Red ginseng)
Other Intervention Name(s)
Korea Red ginseng capsule (3,000 mg/day)
Intervention Description
3 weeks of KRG capsule (3,000 mg/day)
Intervention Type
Drug
Intervention Name(s)
Placebo (for KRG)
Other Intervention Name(s)
Placebo
Intervention Description
Placebos with same shape and size were manufactured and at Korea Ginseng Corporation
Primary Outcome Measure Information:
Title
Liver Enzymes
Description
aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase
Time Frame
3 weeks of KRG
Secondary Outcome Measure Information:
Title
Fatigue as Measured by KRUPP's Fatigue Severity Scale
Description
KRUPP's fatigue severity scale.
The survey has nine questions as following:
my motivation is lower, when I am fatigued
exercise brings on my fatigue
I am easily fatigued
fatigue interferes with my physical functioning
fatigue causes frequent problems for me
my fatigue prevents sustained physical functioning
fatigue interferes with carrying out certain duties and responsibilities
fatigue is among my 3 most disabling symptoms
fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree).
Scores range from 9 to 63, with higher scores indicating higher fatigue
Time Frame
3 weeks of KRG
Title
Pro-inflammatory Cytokine
Description
tumor necrosis factor-alpha, interleukin-6
Time Frame
3 weeks of KRG
Title
Adiponectin
Description
enzyme-linked immunosorbent assay
Time Frame
3 weeks of KRG
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
aspartate aminotransferase (AST) ≥ 50 U/L or alanine aminotransferase (ALT) ≥ 50 U/L, and Fatty liver or Hepatitis
Exclusion Criteria:
viral hepatitis, alcoholic hepatitis, autoimmune hepatitis, pancreatitis, hemochromatosis, Wilson's disease, drug induced liver injury, or cancer
12. IPD Sharing Statement
Learn more about this trial
Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis
We'll reach out to this number within 24 hrs